Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SP Funds S&P 500 Sharia Industry Exclusions ETF (SPUS) vs GeneDx Holdings Corp (WGS) Price & Performance

SP Funds S&P 500 Sharia Industry Exclusions ETFTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

SP Funds S&P 500 Sharia Industry Exclusions ETF vs GeneDx Holdings Corp — how do they compare? SP Funds S&P 500 Sharia Industry Exclusions ETF trades at $59.16, while GeneDx Holdings Corp trades at $82.19 (market cap $2.44B). The key difference: SP Funds S&P 500 Sharia Industry Exclusions ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.

SPUSWGS
Sector
Broad Market / FactorTechnology
52-Week High
$59.51$167.51
52-Week Low
$46.28$34.51
Market Cap
$2.44B
Enterprise Value
$2.48B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SP Funds S&P 500 Sharia Industry Exclusions ETF

SPUS trades at $59.16, up 0.36% with a bullish technical outlook supported by moving averages. The stock shows strong momentum with ADX indicators signaling trend strength, though RSI suggests potential overbought conditions. Dividend payments of $0.03 per share demonstrate consistent shareholder returns, with the next payment scheduled for July 2026.

The stock presents a bullish technical setup with fundamental dividend stability. Key risks include market volatility and concentration in mega-cap technology exposure. Investors should monitor earnings growth and sector rotation trends for sustained performance, with current technical indicators supporting near-term upside potential.

GeneDx Holdings Corp

GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.

Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.

Returns comparison

Trailing returns across standard periods

About SP Funds S&P 500 Sharia Industry Exclusions ETF

SPUS tracks a market-cap weighted index of S&P 500 stocks that adhere to Sharia law. It screens out companies involved in non-compliant business activities such as alcohol, tobacco, gambling, and conventional finance, as well as excluding sectors like Aerospace & Defense, and Data Processing. By focusing on low-leverage stocks, SPUS provides investors with a value-conscious, ethically-aligned exposure to a diversified portfolio of large-cap U.S. equities.

Read more on SPUS

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS